Showing results (81-90 of 99) with videos related to
Sort By:
Pageof 10
British Journal of Cancer|November 27, 2001
First do no harm: extending the debate on the provision of preventive tamoxifenB P Will, K M Nobrega, J M Berthelot, et al.Population Health Metrics|September 5, 2015
The Population Health Model (POHEM): an overview of rationale, methods and applicationsDeirdre A Hennessy, William M Flanagan, Peter Tanuseputro, et al.Chronic Diseases and Injuries in Canada|July 4, 2014
Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova ScotiaR A Marrie, J D Fisk, K J Stadnyk, et al.Lancet (London, England)|August 16, 1997
Randomised trial of home-based psychosocial nursing intervention for patients recovering from myocardial infarctionN Frasure-Smith, F Lespérance, R H Prince, et al.Parkinsonism & Related Disorders|August 28, 2012
Restless legs syndrome outside the blood-brain barrier--exacerbation by domperidone in Parkinson's diseaseS Rios Romenets, Y Dauvilliers, V Cochen De Cock, et al.Brain : a Journal of Neurology|June 1, 1996
Assessment of lesion pathology in multiple sclerosis using quantitative MRI morphometry and magnetic resonance spectroscopyP M Matthews, E Pioro, S Narayanan, et al.Multiple Sclerosis and Related Disorders|September 9, 2015
Comorbidity is associated with pain-related activity limitations in multiple sclerosisK M Fiest, J D Fisk, S B Patten, et al.Neurology|August 29, 2001
Progression of impairment in patients with vascular cognitive impairment without dementiaC Wentzel, K Rockwood, C MacKnight, et al.Journal of Chronic Diseases|January 1, 1986
Observer variation in the classification of mammographic parenchymal patternsN F Boyd, C Wolfson, M Moskowitz, et al.Brain : a Journal of Neurology|April 29, 1998
Imaging axonal damage of normal-appearing white matter in multiple sclerosisL Fu, P M Matthews, N De Stefano, et al.Pageof 10